MOR Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.02M Buy
1,749
+11
+0.6% +$13K 0.76% 24
2026
Q2
$2.08M Sell
1,738
-129
-7% -$132K 0.83% 22
2026
Q1
$1.72M Sell
1,867
-6
-0.3% -$6.08K 0.79% 25
2025
Q4
$2.01M Buy
+1,873
New +$1.79M 0.92% 22

Other funds holding LLY

MOR Wealth Management's LLY Position: Q3 2026 in Review

MOR Wealth Management increased its Eli Lilly (LLY) stake by 0.63% in Q3 2026, buying an estimated $13K and bringing the position to 1,749 shares worth $2.02M. The position accounts for 0.76% of the portfolio, ranked #24.

MOR Wealth Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.08M in Q2 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • MOR Wealth Management held 1,749 shares of Eli Lilly worth $2.02M as of Q3 2026.
  • MOR Wealth Management bought 11 Eli Lilly shares in Q3 2026, an estimated $13K.
  • Eli Lilly made up 0.76% of MOR Wealth Management's portfolio in Q3 2026, its #24 holding.
  • MOR Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • MOR Wealth Management's Eli Lilly position peaked at $2.08M in Q2 2026.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on MOR Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.